T he following and other questions are often raised by employee health nurses involved in the administration of tuberculosis screening programs: Does a positive tuberculin skin test indicate that antibodies to tuberculosis are present? How should a tuberculin skin test result of 5 to 9 mm be interpreted? How does a vaccination with bacille Calrnette-Guerin (BCG) affect a tuberculin skin test result? What is the difference between 1TU, 5 TU, and 250 TU strengths of purified protein derivative (PPD)? What is the booster phenomenon?
BACKGROUND
Before the answers to these questions are considered, a basic understanding of the disease is necessary. Tuberculosis is an infectious disease caused by a mycobacterium. The organism that most often causes tuberculosis in humans is il1ycobacteriumtuberculosis. Mycobacterium bovis can cause disease in cattle, and it can also cause disease in humans, especially in areas of the world where milk is not routinely pasteurized; Mycobacterium aoium usually causes disease in birds, but also can cause disease in immunocompromised humans.
Mycobacteria are spread by droplets from infected saliva, propelled by talking, coughing, or sneezing. Controlling spread of the disease in hospitals and clinics requires teaching clients to use disposable tissues and-to discard these tissues in appropriate receptacles.
At greatest risk for tuberculosis are people in crowded living conditions, those with decreased immunity due At greatest risk for tuberculosis are people in crowded living conditions, those with decreased immunity, those with lowered resistance due to illness or steroid therapy, and those with altered immune states for other reasons.
to very young or advanced age, those with lowered resistance due to illness or steroid therapy, and those with altered immune states for other reasons. While tuberculosis may infect any organ in the body, pulmonary tuberculosis is the most common. When the tuberculosis organism implants itself in multiple body sites, miliary tuberculosis exists (Brunner, 1984) .
After the mycobacterium has entered the body, one of two processes may occur. If a person has an intact, competent immune system, the encounter may end with containment of the mycobacterium. The incident will be regarded as a primary infection. During containment, the body may heal itself by causing gran-uloma to form around the invading organism. Active tubercular disease develops in a person whose immune system is in some way compromised and when the body is unable to contain the organism.
ROLE OF THE IMMUNE SYSTEM
Understanding the role of the immune system in response to tuberculosis is the key to understanding tuberculin skin testing. The human immune system has two components: the humoral system and the cell-mediated (cellular) immune svstem. The humoral system is involv'ed with the production and secretion of antibodies, while cellular immunity is a function of the T-Iymphocytes. The cell-mediated immune system is responsible for protection against most viruses and fungi and is involved in the mediation of cutaneous-delayed hypersensitivity reactions such as the tuberculin skin tests.
A common misconception is that a positive skin test indicates the presence of antibodies against the tuberculosis bacillus. The fact is, those individuals who develop a primary tuberculous infection are "sensitized or allergic to the chemical constituents of the organism" (Brunner, 1984) . Further exposure to these chemical constituents or to the bacillus itself, either alive or killed, results in local inflammation of the tissue. This is the case in a positive tuberculin skin test.
SKIN TESTING
The Mantoux skin test is the preferred tuberculin skin test. Although difficult because of the resistance encountered. A small perpendicular line is drawn at the point of resistance to mark the edge of induration (Figure 2) . This technique is repeated until a total of four lines are drawn at equal distances around the induration. The distance between the lines at the exact edge of induration is then recorded (Figure 3) (Gantz, 1986 ).
An induration of 10 mm or more is considered to be a positive (significant) reaction. A test result of 5 to 9 mm is considered a doubtful (insignificant) reaction. A 5 to 9 mm reaction may be the result of a waning reaction to the sensitivity of a primary infection, the result of an atypical mycobacterium infection, or the consequence of BeG vaccination.
Documentation of a PPD result is induration, not erythema. To accurately interpret the test results, one of two methods may be used: palpation or the ball-point pen technique. Either method is considered reliable (Jordan, 1987) , and a mm/cm ruler is used. Ideally, the ruler should have concentric circles of specific diameters ( Figure 1 ). In the palpation method, the area across the injection site is lightly palpated, starting from the area of normal skin and moving to the margins of induration. The diameter of induration is measured at its widest width.
In the ball-point pen method, a line is drawn toward the margins of induration starting 1 to 2 em from the edges of the reaction. When the ballpoint reaches the edge of induration, movement of the pen becomes more
Interpretation of Results
The reaction is interpreted by written in millimeters. Results are never recorded as positive or negative. This is important, because a significant reaction is one in which an increase of 6 mm or more from a pre-Middle East, Africa, South America, and Southeast Asia have had BCG vaccinations. In work settings with employees from those parts of the world, BCG vaccinations may account for some of the greatest difficulty in interpreting tuberculin skin test results. BCG is a live vaccine prepared from an attenuated strain of M. bovis. Its use has always been controversial. Trials in England have shown that BCG is about 70% effective in preventing infection 5 to 10 years following vaccination. However, trials in India found BCG to be ineffective (Clemens, 1983) .
The Centers for Disease Control (CDC) recommends that employees be tuberculin skin tested regardless of the history of BCG administration (Valenti, 1985) . This is because a tuberculin reaction caused by BCG cannot be differentiated from one which is caused by a mycobacterial infection. Most reactions from BCG fall into the 5 to 9 mm range. Any reading of 10 mm or greater is thought to be caused by a primary infection with M. tuberculosis and should be interpreted as a significant reaction (Snider, 1985) .
The Booster Phenomenon
Test results in the 5 to 9 mm range at initial testing and in the greater than 10 mm range 1 year later are difficult to interpret. This may represent the "booster" phenomenon. The booster phenomenon, an increase in skin test reactivity due to immunologic recall, may occur within 1week to 1year after the initial test (Snider, 1984) .
The booster effect may incorrectly infer that an individual has become a recent converter. A recent converter is an individual whose skin test changes from negative to positive on retesting within 1 to 2 years. Recent converters are those people to whom isoniazid (lNH) prophylaxis is offered.
To eliminate the confusion caused by the booster phenomenon, a twostep PPD procedure is recommended for those individuals who at initial screening have a 5 to 9 mm induration. The first test (T-l) is admin-vious reading of less than 10 mm occurs (Valenti, 1985) .
BCG Vaccinations
Many people from Europe, the Either the palpation method or the ball-point pen technique may be used to measure induration that results from TB skin testi.ng. An induration of 10 mm or greater is considered significant.
The Mantoux test is the tuberculin skin test of choice, the intermediate strength (5 TU) being the most commonly used.
TB skin testing should be administered regardless of patient history of BeG vaccination. To eliminate the confusion caused by the booster phenomenon, a two-step procedure is recommended for individuals who at initialscreening have an induration of 5 to 9 mm.
To understand TB skin testing, it is necessary to have a basic understanding of the disease process and the role of the immune system.
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1. FOLLOW UP Follow-up INH chemoprophylaxis for a period of 6 months to 1 year is recommended for recent converters. A 2-year follow up subsequent to conversion is also recommended, since 2 years is thought to be the period of time when converters are most susceptible to developing the disease (Karus, 1983) .
Individuals who have been PPD positive for a number of years and who subsequently develop the disease usually do so because of age, alteration in immune status, or prolonged illness. These individuals are most likely to develop the disease when the granulomas that walled off the tubercle bacilli break down and the once-encased bacilli are free to cause disease. It should be remembered that although a positive PPD test or a BCG vaccination indicates that the sensitivity developed may afford some protection, it is still possible to develop the disease.
Tuberculosis is not highly contagious, and prolonged contact with an infected individual is usually required before disease develops. If A common misconception is that a positive skin test indicates the presence of antibodies against the tuberculosis bacillus.
an employee is PPD negative and is exposed to a person with acute tuberculosis, the earliest change in the PPD reading would occur in 8 to 10 weeks. Thus, repeat PPD testing is recommended at that time.
Occupational health nurses may have a major role in the administration and follow up of tuberculosis screening programs. To provide appropriate employee counseling, treatment, and referral, an understanding of the disease process, skin testing technique, effects of BCG on skin test results, and interpretation of results is essential. It is important not Nordhaugen, Boyles to become complacent in routine testing, but to continually update knowledge and skills to ensure the provision of optimal care.
